Sees FY25 revenue $2.8B-$2.9B, consensus $2.85B.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GMED:
- Is GMED a Buy, Before Earnings?
- Globus Medical price target lowered to $90 from $97 at Canaccord
- Hold Rating on Globus Medical Amid Management Changes and Spine Business Concerns
- Optimistic Outlook on Globus Medical: Strategic Changes and Positive Q2 Performance Drive Buy Rating
- Globus Medical price target lowered to $88 from $90 at Jefferies